Clinical Research Directory
Browse clinical research sites, groups, and studies.
Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-70 RCT Study
Sponsor: Yonsei University
Summary
One of the most effective drug in the primary prevention of cardiovascular disease is statins. The protective effects of statin on developement of cardiovascular disease has been demonstrated in elderly individuals. Since side effects of statin are more common in elderly individuals than in younger individuals, clinical guidelines recommend that use of low intensity statin is considered in elderly individuals. However, there are few randomized clinical trials evaluating the safety and efficacy of different intensity statins in elderly individuals. This is a multicenter, prospective, randomized clinical trial to compare efficacy and safety between low and high intensity statin for primary prevention of cardiovacsular disease in elderly individuals.
Key Details
Gender
All
Age Range
70 Years - Any
Study Type
INTERVENTIONAL
Enrollment
724
Start Date
2020-03-05
Completion Date
2026-01-16
Last Updated
2025-11-18
Healthy Volunteers
Yes
Interventions
Low intensity statin
Use of low intensity statin for primary prevention of cardiovascular disease.
Moderate intensity statin
Use of moderate intensity statin for primary prevention of cardiovascular disease.
Locations (1)
Division of Cardiology, Cardiovascular Center, Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea